Literature DB >> 15960610

Regulation of cell survival by lipid phosphate phosphatases involves the modulation of intracellular phosphatidic acid and sphingosine 1-phosphate pools.

Jaclyn Long1, Peter Darroch, Kah Fei Wan, Kok Choi Kong, Nicholas Ktistakis, Nigel J Pyne, Susan Pyne.   

Abstract

We have shown previously that LPPs (lipid phosphate phosphatases) reduce the stimulation of the p42/p44 MAPK (p42/p44 mitogen-activated protein kinase) pathway by the GPCR (G-protein-coupled receptor) agonists S1P (sphingosine 1-phosphate) and LPA (lysophosphatidic acid) in serum-deprived HEK-293 cells [Alderton, Darroch, Sambi, McKie, Ahmed, N. J. Pyne and S. Pyne (2001) J. Biol. Chem. 276, 13452-13460]. In the present study, we now show that this can be blocked by pretreating HEK-293 cells with the caspase 3/7 inhibitor, Ac-DEVD-CHO [N-acetyl-Asp-Glu-Val-Asp-CHO (aldehyde)]. Therefore LPP2 and LPP3 appear to regulate the apoptotic status of serum-deprived HEK-293 cells. This was supported further by: (i) caspase 3/7-catalysed cleavage of PARP [poly(ADP-ribose) polymerase] was increased in serum-deprived LPP2-overexpressing compared with vector-transfected HEK-293 cells; and (ii) serum-deprived LPP2- and LPP3-overexpressing cells exhibited limited intranucleosomal DNA laddering, which was absent in vector-transfected cells. Moreover, LPP2 reduced basal intracellular phosphatidic acid levels, whereas LPP3 decreased intracellular S1P in serum-deprived HEK-293 cells. LPP2 and LPP3 are constitutively co-localized with SK1 (sphingosine kinase 1) in cytoplasmic vesicles in HEK-293 cells. Moreover, LPP2 but not LPP3 prevents SK1 from being recruited to a perinuclear compartment upon induction of PLD1 (phospholipase D1) in CHO (Chinese-hamster ovary) cells. Taken together, these data are consistent with an important role for LPP2 and LPP3 in regulating an intracellular pool of PA and S1P respectively, that may govern the apoptotic status of the cell upon serum deprivation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15960610      PMCID: PMC1237135          DOI: 10.1042/BJ20050342

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  37 in total

1.  Sphingosine prevents diacylglycerol signaling to mitogen-activated protein kinase in airway smooth muscle.

Authors:  D Tolan; A M Conway; N J Pyne; S Pyne
Journal:  Am J Physiol       Date:  1997-09

2.  The Dri 42 gene, whose expression is up-regulated during epithelial differentiation, encodes a novel endoplasmic reticulum resident transmembrane protein.

Authors:  D Barilà; M Plateroti; F Nobili; A O Muda; Y Xie; T Morimoto; G Perozzi
Journal:  J Biol Chem       Date:  1996-11-22       Impact factor: 5.157

Review 3.  Phospholipase D: enzymology, mechanisms of regulation, and function.

Authors:  J H Exton
Journal:  Physiol Rev       Date:  1997-04       Impact factor: 37.312

4.  Cloning and characterization of two human isozymes of Mg2+-independent phosphatidic acid phosphatase.

Authors:  M Kai; I Wada; S i Imai; F Sakane; H Kanoh
Journal:  J Biol Chem       Date:  1997-09-26       Impact factor: 5.157

5.  Molecular cloning of two alternatively spliced forms of human phosphatidic acid phosphatase cDNAs that are differentially expressed in normal and tumor cells.

Authors:  D W Leung; C K Tompkins; T White
Journal:  DNA Cell Biol       Date:  1998-04       Impact factor: 3.311

6.  Identification and cDNA cloning of 35-kDa phosphatidic acid phosphatase (type 2) bound to plasma membranes. Polymerase chain reaction amplification of mouse H2O2-inducible hic53 clone yielded the cDNA encoding phosphatidic acid phosphatase.

Authors:  M Kai; I Wada; S Imai; F Sakane; H Kanoh
Journal:  J Biol Chem       Date:  1996-08-02       Impact factor: 5.157

7.  Mice with transgenic overexpression of lipid phosphate phosphatase-1 display multiple organotypic deficits without alteration in circulating lysophosphatidate level.

Authors:  Junming Yue; Kazuaki Yokoyama; Louisa Balazs; Daniel L Baker; David Smalley; Carlos Pilquil; David N Brindley; Gabor Tigyi
Journal:  Cell Signal       Date:  2004-03       Impact factor: 4.315

8.  Sphingosine kinase 1 is an intracellular effector of phosphatidic acid.

Authors:  Christine Delon; Maria Manifava; Eleanor Wood; Dawn Thompson; Sonja Krugmann; Susan Pyne; Nicholas T Ktistakis
Journal:  J Biol Chem       Date:  2004-08-13       Impact factor: 5.157

9.  Lipid phosphate phosphatase-1 regulates lysophosphatidic acid-induced calcium release, NF-kappaB activation and interleukin-8 secretion in human bronchial epithelial cells.

Authors:  Yutong Zhao; Peter V Usatyuk; Rhett Cummings; Bahman Saatian; Donghong He; Tonya Watkins; Andrew Morris; Ernst W M Spannhake; David N Brindley; Viswanathan Natarajan
Journal:  Biochem J       Date:  2005-01-15       Impact factor: 3.857

10.  Photolysis of intracellular caged sphingosine-1-phosphate causes Ca2+ mobilization independently of G-protein-coupled receptors.

Authors:  Dagmar Meyer zu Heringdorf; Karoly Liliom; Michael Schaefer; Kerstin Danneberg; Jonathan H Jaggar; Gabor Tigyi; Karl H Jakobs
Journal:  FEBS Lett       Date:  2003-11-20       Impact factor: 4.124

View more
  32 in total

Review 1.  A novel perspective on stem cell homing and mobilization: review on bioactive lipids as potent chemoattractants and cationic peptides as underappreciated modulators of responsiveness to SDF-1 gradients.

Authors:  M Z Ratajczak; C H Kim; A Abdel-Latif; G Schneider; M Kucia; A J Morris; M J Laughlin; J Ratajczak
Journal:  Leukemia       Date:  2011-09-02       Impact factor: 11.528

Review 2.  Lipid phosphate phosphatases and their roles in mammalian physiology and pathology.

Authors:  Xiaoyun Tang; Matthew G K Benesch; David N Brindley
Journal:  J Lipid Res       Date:  2015-03-26       Impact factor: 5.922

Review 3.  Sphingosine 1-phosphate in coagulation and inflammation.

Authors:  Hideru Obinata; Timothy Hla
Journal:  Semin Immunopathol       Date:  2011-07-31       Impact factor: 9.623

4.  Intracellular localization of sphingosine kinase 1 alters access to substrate pools but does not affect the degradative fate of sphingosine-1-phosphate.

Authors:  Deanna L Siow; Charles D Anderson; Evgeny V Berdyshev; Anastasia Skobeleva; Stuart M Pitson; Binks W Wattenberg
Journal:  J Lipid Res       Date:  2010-04-12       Impact factor: 5.922

Review 5.  Sphingolipids in mitochondria.

Authors:  María José Hernández-Corbacho; Mohamed F Salama; Daniel Canals; Can E Senkal; Lina M Obeid
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2016-09-30       Impact factor: 4.698

6.  Role of lipid phosphate phosphatase 3 in human aortic endothelial cell function.

Authors:  Zahia Touat-Hamici; Henri Weidmann; Yuna Blum; Carole Proust; Hervé Durand; Francesca Iannacci; Veronica Codoni; Pauline Gaignard; Patrice Thérond; Mete Civelek; Sonia A Karabina; Aldons J Lusis; François Cambien; Ewa Ninio
Journal:  Cardiovasc Res       Date:  2016-09-30       Impact factor: 10.787

Review 7.  Sphingolipids in spinal cord injury.

Authors:  Zachary B Jones; Yi Ren
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2016-08-05

Review 8.  Sphingolipids in neurodegeneration (with focus on ceramide and S1P).

Authors:  Guanghu Wang; Erhard Bieberich
Journal:  Adv Biol Regul       Date:  2018-09-22

9.  Regulators of G-Protein signaling RGS10 and RGS17 regulate chemoresistance in ovarian cancer cells.

Authors:  Shelley B Hooks; Phillip Callihan; Molly K Altman; Jillian H Hurst; Mourad W Ali; Mandi M Murph
Journal:  Mol Cancer       Date:  2010-11-02       Impact factor: 27.401

10.  Genetic elevation of sphingosine 1-phosphate suppresses dystrophic muscle phenotypes in Drosophila.

Authors:  Mario Pantoja; Karin A Fischer; Nicholas Ieronimakis; Morayma Reyes; Hannele Ruohola-Baker
Journal:  Development       Date:  2012-11-15       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.